Endothelial function, systemic inflammation and cardiac hemodynamics in different age patients with post infarction chronic heart failure.
DOI:
https://doi.org/10.26641/2307-0404.2018.1.124918Keywords:
myocardial infarction, endothelial dysfunction, cardiac hemodynamicsAbstract
Heart failure (HF) is a major cause of morbidity and mortality. After myocardial infarction, physiological and anatomical ventricular changes occur, There is also an inflammatory reaction with release of cytokines, growth factors and reactive oxygen species production, which contributes to perpetuate ventricular dysfunction. The study was designed to evaluate the level of inflammatory markers (white blood cells and C-reactive protein), endothelial function and cardiac hemodynamic in different age patients with post infarction heart failure. We divided 45 patients with HF with preserved ejection fraction (HFpEF) with mean age 67,5 [65,5; 71,7] years into two main groups. 1st group: 25 patients with HFpEF and history of myocardial infarction. 2nd group: 20 patients with HFpEF and stable angina (without myocardial infarction in anamnesis). Standard laboratory blood tests for erythrocyte sedimentation rate, C-reactive protein, haematological parameters, lipid profile, glucose, renal and liver function tests, echocardiographic examination, endothelial function estimation were performed. Patients with a history of myocardial infarction had significantly higher levels of left ventricle end diastolic volume, left ventricle end systolic dimension (p<0.05). There was estimated direct correlation between LVEDV, LVESD and age - R=0.68 (p<0.05), R=0.52 (p<0.05). Further analysis of cardiac hemodynamics depending on age revealed significant differences between LVEDV indices in patients with myocardial infarction. A significantly higher level of leukocytes was found in patients with HFpEF with a history of myocardial infarction in both groups (p<0.05). A direct correlation between the leukocyte count and age in patients with HFpEF-R = 0.48 (p< 0.05) was also found. Patients with HFpEF with a history of myocardial infarction had a significantly higher level of CRP, including in the age aspect (p<0.05). A direct correlation between CRP level and age was established in patients with HFpEF - R=0.46 (p<0.05). It was revealed that in the older age groups with myocardial infarction the signs of endothelial dysfunction were significantly more frequent (p<0.05). Reverse correlations were established between the level of endothelium dependent vasodilatation (ESVD) and CRP (R=-0.48, p<0.05), triglycerides (R=-0.45, p<0.05), diastolic blood pressure (R=-0.54, p<0.05). Conclusion: high level of inflammation markers, endothelial dysfunction and changes in cardiac hemodynamics were recorded more often in elderly patients with post infarction heart failure.
References
Kuryata OV, Sirenko OYu. [Effect of L-arginine aspartate on endothelial function of blood vessels in patients with arterial hypertension combined with rheumatoid arthritis]. Ukrayinsʹkyy medychnyy chasopys. 2014;5(103):64-66. Ukrainian.
Kuryata OV, Sіrenko OYu. [Subclinical manifestations of atherosclerosis, functional state of the edema and rigidity of vessels in patients with arterial hypertension combined with rheumatoid arthritis]. Aktualʹni problemy suchasnoyi medytsyny: Visnyk Ukrayinsʹkoyi medychnoyi stomatolohichnoyi akademiyi. 2014;3(47):89-95. Ukrainian.
Kuryata AV, Lysunets TK, Noda OYu. [Cochranitis effectiveness in complex therapy in patients with systemic connective tissue diseases with myocardial damage and manifestations of heart failure]. Mezhdunarodnyy meditsinskiy zhurnal. 2012;2:44-49. Russian.
Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-8.
Thijssen DHJ, Black MA, Pyke K, Padilla J, Atkinson GA, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow mediated dilation (fmd) in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2–H12.
Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 2008;60:119-26.
Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115: 390-7.
Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol. 2009;103:1610-15.
Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193-222.
de Berrazueta JR, Guerra-Ruiz A,Garcia-UnzuetaMT, et al. Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. Eur J Heart Fail 2010;12:477-83.
Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37 (27):2129-200.
Nikolaos G Frangogiannis. The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology. 2014;11:255-65.
Gajarsa JJ, Kloner RA: Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16(1):13-21.
Raposeiras Roubín S, Pardal C Barreiro, Roubín-Camiña F, R Ocaranza Sanchez, E Alvarez Castro, B Paradela Dobarro, et al. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction. Rev Port Cardiol. 2013;32:117-22.
Hwang SJ, Melenovsky V, Borlaug BA. Implications of coronary artery disease in heart failure with preserved ejection fraction. J. AmColl Cardiol. 2014;63(25, ptA):2817-27.
Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flowmediated dilatation in humans. Hypertension 2008;51:203-10.
Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of the brachial artery: a meta-analysis. Int J Cardiovasc Imag. 2010;26:631-40.
Akiyama E, Sugiyama S, Matsuzawa Y, et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction,” Journal of the American College of Cardiology. 2012;60(18):1778-86.
Donald AE, Halcox JP, Charakida M, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol. 2008;51:1959-64.
Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acutemyocardial infarction for Medicare beneficiaries: 1998-2010. Circulation. 2013;128(24):2577-84.
Arroyo Espliguero R, Avanzas P, Quiles J, Kaski JC. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease Atherosclerosis. 2009;204:239-43.
De Keulenaer GW, Segers VFM, Zannad F, and Brutsaert DL. The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function. European Journal of Heart Failure. 2017;19:603-14.
Torabi A, Cleland JG, Khan NK, et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J. 2008;29:859-870.
Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail. 2009;11:588-93.
Zornoff LA, Paiva SA,Duarte DR, Spadaro J. Ventricular remodeling after myocardial infarction: concepts and clinical implications. Arq Bras Cardiol. 2009;92(2):157-64.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.